Form 10-K
LA JOLLA PHARMACEUTICAL CO filed this Form 10-K on 03/04/2019
Document Outline
Entire Document (3433.8 KB)
Subdocument 1 - 10-K - 10-K
Page 1 - UNITED STATES
Page 2 - TABLE OF CONTENTS
Page 3 - FORWARD-LOOKING STATEMENTS
Page 4 - N/A
Page 5 - PART I
Page 6 - LJPC-0118
Page 7 - LJ401-HH01
Page 8 - Manufacturing
Page 9 - Sales and Marketing
Page 10 - Government Regulation
Page 11 - Clinical Data Review and Approval in the U.S.
Page 12 - N/A
Page 13 - Clinical Trial Conduct and Product Approval Regulation in Non-U.S. Jurisdictions
Page 14 - Drug Enforcement Agency Regulation
Page 15 - Anti-Kickback, Fraud and Abuse and False Claims Regulation
Page 16 - Patient Privacy and Data Security
Page 17 - www.ljpc.comwww.sec.gov
Page 18 - If we are unable to maintain effective sales, marketing and distribution capabilities to sell and ma
Page 19 - Results from our clinical studies may not be sufficient to obtain regulatory approvals to market our
Page 20 - Clinical trials that we may undertake may be delayed or halted.
Page 21 - Our success in developing and marketing our product and product candidates depends significantly on
Page 22 - Patent policy and rule changes could increase the uncertainties and costs surrounding the prosecutio
Page 23 - In addition to patent protection, we will need to successfully preserve our trade secrets. If we are
Page 24 - Our product and product candidates may cause undesirable side effects or have other properties that
Page 25 - We may not be successful in our efforts to identify, license, discover, develop, or commercialize ad
Page 26 - If the market opportunities for our products are smaller than we believe, our revenue may be adverse
Page 27 - Current and future legislation and court rulings may increase the difficulty and cost needed to obta
Page 28 - Recent partial shutdowns of the U.S. Government have adversely affected the ability of companies in
Page 29 - II. RISK FACTORS RELATED SPECIFICALLY TO OUR STOCK
Page 30 - Because we do not expect to pay dividends on our common stock in the foreseeable future, you must re
Page 31 - Item 6. Selected Financial Data.
Page 32 - Inventory Valuation
Page 33 - Recent Accounting Pronouncements
Page 34 - Years Ended December 31, 2018 and 2017
Page 35 - Liquidity and Capital Resources
Page 36 - Item 8. Financial Statements and Supplementary Data.
Page 37 - REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Page 38 - Item 9B. Other Information.
Page 39 - PART IV
Page 40 - Item 16. Form 10-K Summary.
Page 41 - SIGNATURES
Page 42 - REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Page 43 - LA JOLLA PHARMACEUTICAL COMPANY
Page 44 - LA JOLLA PHARMACEUTICAL COMPANY
Page 45 - La Jolla Pharmaceutical Company
Page 46 - LA JOLLA PHARMACEUTICAL COMPANY
Page 47 - La Jolla Pharmaceutical Company
Page 48 - La Jolla Pharmaceutical Company
Page 49 - La Jolla Pharmaceutical Company
Page 50 - La Jolla Pharmaceutical Company
Page 51 - La Jolla Pharmaceutical Company
Page 52 - La Jolla Pharmaceutical Company
Page 53 - La Jolla Pharmaceutical Company
Page 54 - La Jolla Pharmaceutical Company
Page 55 - La Jolla Pharmaceutical Company
Page 56 - La Jolla Pharmaceutical Company
Page 57 - La Jolla Pharmaceutical Company
Page 58 - La Jolla Pharmaceutical Company
Page 59 - La Jolla Pharmaceutical Company
Page 60 - La Jolla Pharmaceutical Company
Page 61 - La Jolla Pharmaceutical Company
Subdocument 2 - EX-21.1 - EXHIBIT 21.1
Page 1 - N/A
Subdocument 3 - EX-23.1 - EXHIBIT 23.1
Page 1 - N/A
Subdocument 4 - EX-31.1 - EXHIBIT 31.1
Page 1 - N/A
Subdocument 5 - EX-31.2 - EXHIBIT 31.2
Page 1 - N/A
Subdocument 6 - EX-32.1 - EXHIBIT 32.1
Page 1 - N/A
XBRL Item - EX-101.INS - XBRL INSTANCE DOCUMENT (What's this?)
XBRL Item - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT (What's this?)
XBRL Item - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT (What's this?)
XBRL Item - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT (What's this?)
XBRL Item - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT (What's this?)
XBRL Item - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT (What's this?)
XBRL Viewer


Print Page Print PageE-mail Page E-mail PageRSS Feeds RSS FeedsE-mail Alerts E-mail AlertsIR Contacts IR Contacts